ClinicalTrials.Veeva

Menu

Comparison Of Normal Walking Vs Brisk Walking In Over-Weight Adults

R

Riphah International University

Status

Completed

Conditions

Overweight
Walking

Treatments

Other: Normal Walking
Other: Brisk Walking

Study type

Interventional

Funder types

Other

Identifiers

NCT05854797
REC/01412 SADIA MUNAWAR

Details and patient eligibility

About

The goal of this clinical trial is to see the comparison of normal walking vs brisk walking on body fat, hypertension, diabetes, and level of happiness in over-weight adults. The main question it aims to answer is:

Will there be a difference between the effectiveness of normal walking and brisk walking on improving body fat, hypertension, diabetes, and level of happiness in over-weight adults..

The participants will be divided into two groups; group A and group B. Group A will perform normal walk and Group B will perform brisk walk.

Full description

In the modern times, despite the fact that the benefits of regular physical activity are widely known, the choice of a sedentary lifestyle is increasing in prevalence. With the help of simple and natural movements, walking is considered as a moderate level of workout intensity that promotes a long and healthy lifespan. Meanwhile, it provides the added advantage to individuals by reducing chances of injury, making it an excellent choice for middle-aged and elderly individuals. Walking tends to be the widely preferred choice of most diabetic patients worldwide for improving glycemic control. Moghetti et al. showed the correlation between walking and type 2 diabetes in their recent research where they employed meta-analysis (supported with short and long term RCTs) to prove that sufficient amount of walking can lead to improved levels of HbA1c. Walking can improve functional capacity of people with T2DM and cast favorable impacts on chronic complications of diabetes The research carried out to advocate strong relation between walking and healthy lifestyle is widely available to us. However, it mainly focuses on elderly people (with age above 60) instead of young and middle-aged people who have been equally pushed at the verge of risks to develop obesity, cardiovascular diseases and T2D due to astonishingly common sedentary lifestyle prevailing in today's world. Also, it is limited in terms of defined intensities for walking and their comparison for guiding an appropriate course of action for obese or hypertensive adults. Therefore, this research will evaluate and compare the impacts of normal and brisk walking on middle-aged people struggling with diabetes, hypertension, obesity or other cardiovascular diseases. Also, it will define the basis for a well-informed and focussed approach to enhance quality of life in adults.

Enrollment

20 patients

Sex

All

Ages

36 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age between 36-55 years
  • Hypertensive middle-aged adults
  • BMI > 25
  • Type 2 diabetes middle-adults
  • Body fat > 25%

Exclusion criteria

  • Severe psychological illness
  • Physical defect or deformity
  • Experience of diabetic coma
  • Engagement in other training programs
  • Any other serious illness like TB, cancer.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups

Normal Walking Group
Active Comparator group
Description:
Adhering to FITT method, normal walking will be performed 5 days a week (frequency) to ensure optimal results. Speed (intensity) for normal will be 3.5 mph
Treatment:
Other: Normal Walking
Brisk Walking Group
Experimental group
Description:
Adhering to FITT method, brisk walking will be performed 5 days a week (frequency) to ensure optimal results. Speed (intensity) for normal will be 4.5 mph.
Treatment:
Other: Brisk Walking

Trial contacts and locations

1

Loading...

Central trial contact

Jawad Naweed, MS-SPT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems